Hämatologisch-onkologische Praxis

Augsburg 86150

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer — Completed